Auris Medical Holding AG IPO Research Information

Auris Medical Holding AG IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Auris Medical Holding AG, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Auris Medical Holding AG	EARS - NASDAQ	$10.00-$12.00	$6.00	$6.10	9.4 million	8/6/2014
Underwriter(s): Jefferies, Leerink Partners
Co-Manager(s): JMP Securities, Needham & Co.
Industry: Health Care
Filing(s): Filed 2014-06-27 Terms Added 2014-07-21 Amended Terms 2014-08-05

Auris Medical Holding AG Quote & Chart - Click for current quote - EARS

About Auris Medical Holding AG (adapted from Auris Medical Holding AG prospectus):
They are a clinical-stage biopharmaceutical company focused on the development of novel products for the treatment of inner ear disorders.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "EARS" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.